ロード中...
RARE-31. DUAL BRAF/MEK THERAPY FOR PATIENTS WITH BRAF V600E-MUTATED TUMORS: DRAMATIC CLINICAL AND RADIOGRAPHIC RESPONSES AND A REDUCTION IN CUTANEOUS TOXICITY
INTRODUCTION: The BRAF V600E mutation is a common oncogenic driver present in a variety of primary brain tumors including pleomorphic xanthoastrocytoma (66%), pilocytic astrocytoma (9%), primary and secondary glioblastoma (2% and 6%), giant cell glioblastoma (7%), ganglioglioma (18%) and papillary c...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692242/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.875 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|